CG
ARCT icon

Cutler Group’s Arcturus Therapeutics ARCT Stock Holding History

Cutler Group’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-600
Closed -$10.8K – 3744
2022
Q4 		$10K Sell
600
-200
-25% -$3.49K ﹤0.01% 2676
2022
Q3 		$11K Sell
800
-7,908
-91% -$133K ﹤0.01% 3045
2022
Q2 		$137K Sell
8,708
-4,848
-36% -$95.1K 0.01% 1242
2022
Q1 		$365K Buy
13,556
+11,938
+738% +$305K 0.02% 815
2021
Q4 		$59K Buy
1,618
+731
+82% +$29.8K ﹤0.01% 2264
2021
Q3 		$42K Sell
887
-2,013
-69% -$90.2K ﹤0.01% 2652
2021
Q2 		$98K Buy
2,900
+2,366
+443% +$80.1K ﹤0.01% 1898
2021
Q1 		$22K Sell
534
-9,966
-95% -$594K ﹤0.01% 3123
2020
Q4 		$455K Buy
10,500
+4,798
+84% +$325K 0.02% 677
2020
Q3 		$244K Buy
5,702
+1,864
+49% +$92.5K 0.02% 833
2020
Q2 		$179K Buy
3,838
+2,838
+284% +$97.8K 0.01% 934
2020
Q1 		$13K Sell
1,000
-200
-17% -$2.56K ﹤0.01% 2556
2019
Q4 		$13K Buy
1,200
+400
+50% +$4.19K ﹤0.01% 2469
2019
Q3 		$8K Sell
800
-100
-11% -$1.08K ﹤0.01% 2722
2019
Q2 		$8K Buy
+900
New +$6.61K ﹤0.01% 2807
2017
Q1 		– Sell
-2,007
Closed -$29K – 6321
2016
Q4 		$29K Sell
2,007
-1,440
-42% -$21.5K ﹤0.01% 3079
2016
Q3 		$59K Sell
3,447
-266
-7% -$8.59K ﹤0.01% 2293
2016
Q2 		$116K Buy
3,713
+486
+15% +$15.3K 0.01% 1556
2016
Q1 		$85K Buy
3,227
+328
+11% +$11.1K 0.01% 1760
2015
Q4 		$127K Buy
+2,899
New +$131K 0.01% 1555

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Cutler Group's ARCT Position: Q1 2023 in Review

Cutler Group sold out of Arcturus Therapeutics (ARCT) in Q1 2023, closing a stake of 600 shares — an estimated $10.8K sold.

Cutler Group first reported a position in ARCT in Q4 2015 and held it in 20 quarters. The position peaked at $455K in Q4 2020. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2023.

  • Cutler Group reported no remaining Arcturus Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 600 Arcturus Therapeutics shares in Q1 2023, an estimated $10.8K.
  • Cutler Group first reported a position in Arcturus Therapeutics in Q4 2015 and held it in 20 quarters.
  • Cutler Group's Arcturus Therapeutics position peaked at $455K in Q4 2020.
  • 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.